<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLoS Computational Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1553-734X</issn>
    <issn pub-type="epub">1553-7358</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8221786</article-id>
    <article-id pub-id-type="pmid">34115744</article-id>
    <article-id pub-id-type="publisher-id">PCOMPBIOL-D-20-01678</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1008979</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Computer and Information Sciences</subject>
        <subj-group>
          <subject>Network Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Oncology</subject>
          <subj-group>
            <subject>Cancers and Neoplasms</subject>
            <subj-group>
              <subject>Breast Tumors</subject>
              <subj-group>
                <subject>Breast Cancer</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Computer and Information Sciences</subject>
        <subj-group>
          <subject>Software Engineering</subject>
          <subj-group>
            <subject>Computer Software</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Engineering and Technology</subject>
        <subj-group>
          <subject>Software Engineering</subject>
          <subj-group>
            <subject>Computer Software</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Gene Expression</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Pharmacology</subject>
          <subj-group>
            <subject>Drug Interactions</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Computer and Information Sciences</subject>
        <subj-group>
          <subject>Computer Architecture</subject>
          <subj-group>
            <subject>User Interfaces</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Oncology</subject>
          <subj-group>
            <subject>Cancers and Neoplasms</subject>
            <subj-group>
              <subject>Genitourinary Tract Tumors</subject>
              <subj-group>
                <subject>Prostate Cancer</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Urology</subject>
          <subj-group>
            <subject>Prostate Diseases</subject>
            <subj-group>
              <subject>Prostate Cancer</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Computational Biology</subject>
          <subj-group>
            <subject>Genome Complexity</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
            <subj-group>
              <subject>Genome Complexity</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>netgsa: Fast computation and interactive visualization for topology-based pathway enrichment analysis</article-title>
      <alt-title alt-title-type="running-head">netgsa: Fast computation and interactive visualization for pathway enrichment analysis</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6372-3538</contrib-id>
        <name>
          <surname>Hellstern</surname>
          <given-names>Michael</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Data curation</role>
        <role content-type="https://casrai.org/credit/">Formal analysis</role>
        <role content-type="https://casrai.org/credit/">Software</role>
        <role content-type="https://casrai.org/credit/">Visualization</role>
        <role content-type="https://casrai.org/credit/">Writing – original draft</role>
        <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6294-227X</contrib-id>
        <name>
          <surname>Ma</surname>
          <given-names>Jing</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Conceptualization</role>
        <role content-type="https://casrai.org/credit/">Data curation</role>
        <role content-type="https://casrai.org/credit/">Methodology</role>
        <role content-type="https://casrai.org/credit/">Software</role>
        <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8850-2758</contrib-id>
        <name>
          <surname>Yue</surname>
          <given-names>Kun</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Formal analysis</role>
        <role content-type="https://casrai.org/credit/">Methodology</role>
        <role content-type="https://casrai.org/credit/">Software</role>
        <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8846-3533</contrib-id>
        <name>
          <surname>Shojaie</surname>
          <given-names>Ali</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Conceptualization</role>
        <role content-type="https://casrai.org/credit/">Methodology</role>
        <role content-type="https://casrai.org/credit/">Supervision</role>
        <role content-type="https://casrai.org/credit/">Writing – original draft</role>
        <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>Department of Biostatistics, University of Washington, Seattle, Washington</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Pertea</surname>
          <given-names>Mihaela</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>Johns Hopkins University, UNITED STATES</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p>The authors have declared that no competing interests exist.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>ashojaie@uw.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>6</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>11</day>
      <month>6</month>
      <year>2021</year>
    </pub-date>
    <volume>17</volume>
    <issue>6</issue>
    <elocation-id>e1008979</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>9</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>18</day>
        <month>4</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2021 Hellstern et al</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Hellstern et al</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="pcbi.1008979.pdf"/>
    <abstract>
      <p>Existing software tools for topology-based pathway enrichment analysis are either computationally inefficient, have undesirable statistical power, or require expert knowledge to leverage the methods’ capabilities. To address these limitations, we have overhauled NetGSA, an existing topology-based method, to provide a computationally-efficient user-friendly tool that offers interactive visualization. Pathway enrichment analysis for thousands of genes can be performed in minutes on a personal computer without sacrificing statistical power. The new software also removes the need for expert knowledge by directly curating gene-gene interaction information from multiple external databases. Lastly, by utilizing the capabilities of Cytoscape, the new software also offers interactive and intuitive network visualization.</p>
    </abstract>
    <abstract abstract-type="summary">
      <title>Author summary</title>
      <p>With the increase in publicly available pathway topology information, topology-based pathway enrichment methods have become effective tools to analyze omics data. While many different methods are available, none are uniformly best. This paper focused on overhauling an existing topology-based method, NetGSA. The three key improvements included dramatically reduced computation time so pathway enrichment can be performed within minutes on a personal computer, integration of publicly available pathway topology databases so users can easily leverage the entire capabilities of the NetGSA method, and facilitating interactive visualization of results through an interface with Cytoscape, a popular network visualization tool. The improved NetGSA was compared to the previous version as well as other similar pathway topology-based methods and achieves competitive statistical power. With these improvements and NetGSA’s flexibility to address a diverse set of problems and data types, we believe that the new NetGSA can be a useful tool for practitioners. The updated NetGSA is available on CRAN at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://cran.r-project.org/web/packages/netgsa/index.html" ext-link-type="uri">https://cran.r-project.org/web/packages/netgsa/index.html</ext-link> and the development version is available on GitHub at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/mikehellstern/netgsa" ext-link-type="uri">https://github.com/mikehellstern/netgsa</ext-link>.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100008982</institution-id>
            <institution>National Science Foundation</institution>
          </institution-wrap>
        </funding-source>
        <award-id>DMS/NIGMS-1561814</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8846-3533</contrib-id>
          <name>
            <surname>Shojaie</surname>
            <given-names>Ali</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
            <institution>National Institutes of Health</institution>
          </institution-wrap>
        </funding-source>
        <award-id>R01-GM114029</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8846-3533</contrib-id>
          <name>
            <surname>Shojaie</surname>
            <given-names>Ali</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>This work was supported by the National Science Foundation [DMS/NIGMS-1561814] (AS) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.nsf.gov/" ext-link-type="uri">https://www.nsf.gov/</ext-link> and the National Institutes of Health [R01-GM114029] (AS) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.nih.gov/" ext-link-type="uri">https://www.nih.gov/</ext-link>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="5"/>
      <table-count count="2"/>
      <page-count count="10"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>PLOS Publication Stage</meta-name>
        <meta-value>vor-update-to-uncorrected-proof</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>Publication Update</meta-name>
        <meta-value>2021-06-23</meta-value>
      </custom-meta>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>All source code and data are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/mikehellstern/netgsaSoftware" ext-link-type="uri">https://github.com/mikehellstern/netgsaSoftware</ext-link>.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>All source code and data are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/mikehellstern/netgsaSoftware" ext-link-type="uri">https://github.com/mikehellstern/netgsaSoftware</ext-link>.</p>
  </notes>
</front>
<body>
  <disp-quote>
    <p>This is a <italic toggle="yes">PLOS Computational Biology</italic> Software paper.</p>
  </disp-quote>
  <sec sec-type="intro" id="sec001">
    <title>Introduction</title>
    <p>Pathway enrichment analysis methods have become standard tools for analyzing omics data [<xref rid="pcbi.1008979.ref001" ref-type="bibr">1</xref>]. While earlier generations of methods are still widely used, the third generation, topology-based methods, may offer advantages by incorporating the pathway structure [<xref rid="pcbi.1008979.ref002" ref-type="bibr">2</xref>]. Despite these advantages, limitations in existing methods and software have hindered wide adoption of topology-based methods [<xref rid="pcbi.1008979.ref001" ref-type="bibr">1</xref>]. To overcome these limitations, this paper provides important updates to an existing statistically powerful method, NetGSA [<xref rid="pcbi.1008979.ref003" ref-type="bibr">3</xref>, <xref rid="pcbi.1008979.ref004" ref-type="bibr">4</xref>], which was previously difficult to use and computationally expensive [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>].</p>
    <p>Many topology-based methods have been proposed in the literature, but there is no consistent best choice for a given problem. For example, computationally efficient methods, such as SPIA [<xref rid="pcbi.1008979.ref006" ref-type="bibr">6</xref>] and PRS [<xref rid="pcbi.1008979.ref007" ref-type="bibr">7</xref>] require differentially expressed genes which may or may not be detected. Methods such as topologyGSA [<xref rid="pcbi.1008979.ref008" ref-type="bibr">8</xref>] and Pathway-Express [<xref rid="pcbi.1008979.ref009" ref-type="bibr">9</xref>] have specific input requirements and thus may not be applicable to, e.g., metabolomics data [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>]. The current version of NetGSA, a statistically powerful method, is computationally slow. Finally, a major hurdle common to all topology-based methods is their reliance on external information [<xref rid="pcbi.1008979.ref001" ref-type="bibr">1</xref>]. This information is often spread across several databases, such as KEGG [<xref rid="pcbi.1008979.ref010" ref-type="bibr">10</xref>], Reactome [<xref rid="pcbi.1008979.ref011" ref-type="bibr">11</xref>], and PantherDB [<xref rid="pcbi.1008979.ref012" ref-type="bibr">12</xref>], making aggregation challenging for non-expert users.</p>
    <p>These issues present a clear need for computationally efficient, statistically powerful, and user-friendly software. To address this need, we have completely overhauled the <monospace>netgsa</monospace> R package, an implementation of the NetGSA methodology. In addition to desirable statistical power, NetGSA has a number of appealing features. Most notably, it provides a flexible framework for testing pathway enrichment in complex experiments [<xref rid="pcbi.1008979.ref013" ref-type="bibr">13</xref>] and diverse data types, and is robust to errors or incompleteness of existing biological network databases [<xref rid="pcbi.1008979.ref003" ref-type="bibr">3</xref>]. However, the implementation of the method in the <monospace>netgsa</monospace> package was overly complicated, requiring users to manually extract and supply biological network information. The package was also prohibitively slow for analyzing data with large numbers of omics measures. To address these shortcomings, we have drastically simplified the <monospace>netgsa</monospace> workflow to three functions and <monospace>netgsa</monospace> now connects seamlessly with several knowledge bases and interactive visualization tools to vastly improve the user experience. <monospace>netgsa</monospace>’s computation has also been significantly improved and pathway enrichment can now be performed in minutes on a personal laptop with no loss in statistical power. <xref rid="pcbi.1008979.g001" ref-type="fig">Fig 1</xref> gives an overview of the NetGSA methodology and changes in the <monospace>netgsa</monospace> software.</p>
    <fig position="float" id="pcbi.1008979.g001">
      <object-id pub-id-type="doi">10.1371/journal.pcbi.1008979.g001</object-id>
      <label>Fig 1</label>
      <caption>
        <title>NetGSA methodology highlighting package updates.</title>
        <p>(A) NetGSA takes external gene interactions, a matrix of pathways to test, and expression data as inputs. The new netgsa incorporates existing external databases such as KEGG, Reactome, NCI, etc. (B) Weighted adjacency matrices are calculated for each condition (two conditions shown). Users now have the option to use clustering in calculating the weighted adjacency matrices. (C) Pathway enrichment is performed using weighted adjacency matrices. In addition to REML, users can estimate the variance parameters using REHE. Faster matrix calculations are also incorporated in C++ (B &amp; C). (D) Visualization is now available with the option to use either Cytoscape or igraph. (E) Power simulations involved steps (B) and (C).</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.1008979.g001" position="float"/>
    </fig>
  </sec>
  <sec sec-type="materials|methods" id="sec002">
    <title>Design and implementation</title>
    <p>The updated version of <monospace>netgsa</monospace> includes important user interface improvements, streamlining the workflow from analysis to visualization. The package also continues to support diverse omics data types, including gene expression, proteomics and metabolomics data sets. However, to simplify the presentation, we describe the <monospace>netgsa</monospace>’s features in the context of gene expression data sets.</p>
    <sec id="sec003">
      <title>User interface: Input</title>
      <p>The inputs to <monospace>netgsa</monospace> are gene interactions (optional), a list of pathways to test, and gene expression data. Gene interaction information is an optional input as <monospace>netgsa</monospace> can directly learn the network from expression data. However, this information is recommended for leveraging the full power of the NetGSA method. Previously, users had to manually supply this information. This was a time consuming task as there are numerous fragmented databases each using different identifiers. <monospace>netgsa</monospace> now interfaces directly with <monospace>graphite</monospace> [<xref rid="pcbi.1008979.ref014" ref-type="bibr">14</xref>] to search for interaction information so users can easily access all of <monospace>netgsa</monospace>’s functionality. Users can specify any of NDEx [<xref rid="pcbi.1008979.ref015" ref-type="bibr">15</xref>] or the eight pathway databases available in <monospace>graphite</monospace>—KEGG [<xref rid="pcbi.1008979.ref010" ref-type="bibr">10</xref>], BioCarta [<xref rid="pcbi.1008979.ref016" ref-type="bibr">16</xref>], Reactome [<xref rid="pcbi.1008979.ref011" ref-type="bibr">11</xref>], NCI/Nature Pathway Interaction Database [<xref rid="pcbi.1008979.ref017" ref-type="bibr">17</xref>], PathBank [<xref rid="pcbi.1008979.ref018" ref-type="bibr">18</xref>], PantherDB [<xref rid="pcbi.1008979.ref012" ref-type="bibr">12</xref>], smpdb [<xref rid="pcbi.1008979.ref019" ref-type="bibr">19</xref>], PharmGKB [<xref rid="pcbi.1008979.ref020" ref-type="bibr">20</xref>]—and <monospace>netgsa</monospace> will retrieve the interaction information. This functionality is available with a single R function: <monospace>obtainEdgeList()</monospace>.</p>
      <p>The next step in the <monospace>netgsa</monospace> workflow is to estimate the weighted adjacency matrices for each condition using the interaction network collected. The new <monospace>prepareAdjMat()</monospace> function now detects the network type (directed/undirected), compiles the interaction information for users, and estimates the weighted adjacency matrix for each condition. With these improvements, pathway enrichment can be performed with three simple functions as shown in <xref rid="pcbi.1008979.g002" ref-type="fig">Fig 2</xref>. Alternatively, <monospace>NetGSAq()</monospace> can also be used to perform weighted adjacency matrix estimation and pathway enrichment in a single function call.</p>
      <fig position="float" id="pcbi.1008979.g002">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1008979.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>The new <monospace>netgsa</monospace> workflow in R.</title>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.1008979.g002" position="float"/>
      </fig>
    </sec>
    <sec id="sec004">
      <title>User interface: Output</title>
      <p>Pathway enrichment analysis typically consists of large biological networks which are difficult to visualize. Static images are either too specific, offering only a local view, or too broad, yielding incomprehensible pictures. To remedy this, <monospace>netgsa</monospace> now connects directly with Cytoscape [<xref rid="pcbi.1008979.ref021" ref-type="bibr">21</xref>], a Java-based interactive network visualization tool.</p>
      <p>Cytoscape offers an intuitive and user-friendly interactive display. Users simply need to have Cytoscape installed and running and use the <monospace>plot()</monospace> function in <monospace>netgsa</monospace> to generate visualizations in Cytoscape. The default network plot displays pathways as nodes and between pathway interactions as edges. Two pathways are connected if at least one gene from each pathway are connected. By default, pathway nodes are colored according to both FDR adjusted <italic toggle="yes">p</italic>-values and values of the test statistic returned by <monospace>NetGSA()</monospace>; all data are loaded into Cytoscape, so further customization is available for users familiar with the software. Additionally, the subnetwork containing only statistically significant pathways is also plotted to reduce visual complexity. The visualizations use Cytoscape’s nested network format, so users can easily zoom-in to see the pathway members and their interactions. See <xref rid="pcbi.1008979.g003" ref-type="fig">Fig 3</xref> for an example visualization produced by <monospace>netgsa</monospace> in Cytoscape based on breast cancer gene expression data from The Cancer Genome Atlas [<xref rid="pcbi.1008979.ref022" ref-type="bibr">22</xref>]. When Cytoscape is not open or is unavailable, the network is plotted using the <monospace>igraph</monospace> package in R.</p>
      <fig position="float" id="pcbi.1008979.g003">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1008979.g003</object-id>
        <label>Fig 3</label>
        <caption>
          <title>Example of a nested network Cytoscape plot for breast cancer data.</title>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.1008979.g003" position="float"/>
      </fig>
    </sec>
    <sec id="sec005">
      <title>Computational improvements</title>
      <p>The new version of <monospace>netgsa</monospace> couples user interface improvements with computational advances. Users can now choose the Restricted Haseman-Elston (REHE) method (set as default) [<xref rid="pcbi.1008979.ref023" ref-type="bibr">23</xref>] to estimate the variance components of the latent variable model for inference. Previously, the variance components were estimated by Restricted Maximum Likelihood (REML) based on a Gaussian likelihood. This maximization procedure required computing the gradient and Hessian of the profile log-likelihood, a computationally expensive procedure. By using a constrained method of moments estimator, the REHE method is much more efficient than REML. The increase in efficiency is particularly salient for large data sets. Additionally, users can estimate the adjacency matrices via the <monospace>cluster</monospace> option (set as default) in <monospace>prepareAdjMat()</monospace>, which is referred to as “clustering” in this paper.</p>
      <p>To cluster genes, the 0–1 adjacency matrix from the gene interactions in e.g. <monospace>obtainEdgeList()</monospace> is used to identify connected components in the network. Next, six clustering algorithms from the <monospace>igraph</monospace> package, specifically <monospace>cluster_walktrap</monospace>, <monospace>cluster_leading_eigen</monospace>, <monospace>cluster_fast_greedy</monospace>, <monospace>cluster_label_prop</monospace>, <monospace>cluster_infomap</monospace>, and <monospace>cluster_louvain</monospace>, are run on each connected component &gt;1,000 genes. In order to ensure clustering reduces computational complexity, algorithms producing a maximum cluster size &gt;1,000 genes are discarded and among the remaining, the algorithm with the smallest edge loss is chosen. Weighted adjacency matrices are estimated for each cluster and reassembled into a block diagonal matrix as the final estimate of the weighted adjacency matrix for the entire network. By leveraging this block diagonal structure, clustering can reduce the computational complexity of estimating the weighted adjacency matrix by orders of magnitude; see <xref rid="pcbi.1008979.g004" ref-type="fig">Fig 4</xref> for an illustration. The new version of <monospace>netgsa</monospace> also incorporates much faster matrix calculations in <monospace>C++</monospace> through the <monospace>RcppEigen</monospace> package.</p>
      <fig position="float" id="pcbi.1008979.g004">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1008979.g004</object-id>
        <label>Fig 4</label>
        <caption>
          <title>Illustration of block diagonalization and clustering in calculating weighted adjacency matrix.</title>
          <p>(A) The network is broken into clusters. (B) Weighted adjacency matrix estimation is performed on each cluster separately. (C) Cluster specific matrices are recombined into a single matrix.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.1008979.g004" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="results" id="sec006">
    <title>Results</title>
  </sec>
  <sec id="sec007">
    <title>Power analysis</title>
    <p>Reducing the network to a block diagonal structure through cluster detection and efficient estimation of variance components dramatically reduces the computation time. However, these improvements would be useless if they lead to diminished statistical power or inflated type-I error.</p>
    <p>To evaluate the statistical power of the new <monospace>netgsa</monospace> software, the datasets and dysregulation frameworks in [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>] were used to estimate statistical power with and without clustering. There were a total of three datasets, two of which come from The Cancer Genome Atlas (TCGA). The first involves an analysis of primary breast cancers. Gene expression data was collected for 2784 genes on 520 samples, of which 403 were estrogen-receptor-positive (ER+) and 117 were estrogen-receptor-negative (ER-) [<xref rid="pcbi.1008979.ref022" ref-type="bibr">22</xref>]. The pathways tested were 114 signaling and metabolic pathways from KEGG [<xref rid="pcbi.1008979.ref010" ref-type="bibr">10</xref>]. The second comes from a prostate cancer study which measured gene expression of 2952 genes for 264 case and 160 control subjects [<xref rid="pcbi.1008979.ref024" ref-type="bibr">24</xref>]. For this data, 112 KEGG signaling and metabolic pathways were analyzed. The final dataset is much smaller and measured metabolic profiles among 41 non-diabetic and 30 diabetic mice for 100 selected metabolites [<xref rid="pcbi.1008979.ref025" ref-type="bibr">25</xref>].</p>
    <p>To introduce artifical signal to estimate the statistical power, data for each gene or metabolite was centered and scaled to have zero mean and unit variance. A subset of genes or metabolites were chosen to be dysregulated based on three different dysregulation frameworks detailed in [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>]. If a gene was dysregulated, a mean signal was added for a chosen condition (e.g. in the breast cancer data no signal was added to data from ER- subjects, but the mean signal was added to data from ER+ subjects). Three different mean signals were used: 0.2, 0.3, 0.4. Pathways with at least one dysregulated gene were used to assess power and those with no dysregulated genes were used to evaluate type-I error. An FDR cut-off of <italic toggle="yes">α</italic> = 0.05 was used to identify statistical significance. Due to computational considerations, REML power calculations were performed on each pathway separately, while REHE calculations were performed on the entire network. As an additional comparison, REHE was also run on each pathway separately and achieves similar power to REML by pathway (<xref rid="pcbi.1008979.s001" ref-type="supplementary-material">S1 Appendix</xref>). However, this approach may not offer significant reduction in computational time compared with REHE with clustering. Therefore, we recommend using NetGSA with REHE and clustering options.</p>
    <p>Each pathway was grouped based on its number of dysregulated genes: None, (0,5], (5,10], &gt;10. For example, the Galactose metabolism pathway tested in the breast cancer dataset had 4 dysregulated genes under the betweeness dysregulation framework [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>]. Power estimates were averaged over all pathways and datasets for each group and are displayed in <xref rid="pcbi.1008979.g005" ref-type="fig">Fig 5A</xref> along with the standard errors. The “None” group shows a mean power of 0 suggesting that type-I error is well controlled in all settings. For all other numbers of dysregulated genes, mean power is higher using REHE with clustering compared to both REHE without clustering and REML. Standard errors across the methods also appear to be comparable. Similar results were obtained when analyzing power for each level of dysregulation and aggregating based on pathway size rather than number of dysregulated genes, with power increasing as mean dysregulation and pathway size increase respectively (<xref rid="pcbi.1008979.s001" ref-type="supplementary-material">S1 Appendix</xref>).</p>
    <fig position="float" id="pcbi.1008979.g005">
      <object-id pub-id-type="doi">10.1371/journal.pcbi.1008979.g005</object-id>
      <label>Fig 5</label>
      <caption>
        <p>(A) Power analysis for all datasets and all mean dysregulations, grouped by number of dysregulated genes in pathways; the “None” group corresponds to null pathways. (B) Power comparison for all mean dysregulations for breast cancer data. The methods considered were CAMERA; DEGraph; PE.noCut (Pathway-Express without cut-offs); NetGSA.REML (NetGSA with REML); NetGSA.REHE.Cl (NetGSA with REHE and clustering); and NetGSA.REHE.nCl (NetGSA with REHE and no clustering).</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.1008979.g005" position="float"/>
    </fig>
    <p>In addition to comparing against the old software, <xref rid="pcbi.1008979.g005" ref-type="fig">Fig 5B</xref> compares the recommended new <monospace>netgsa</monospace> software, i.e., NetGSA with REHE and clustering (NetGSA.REHE.Cl), to existing methods using a similar methodology to [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>]. Specifically DEGraph [<xref rid="pcbi.1008979.ref026" ref-type="bibr">26</xref>], CAMERA [<xref rid="pcbi.1008979.ref027" ref-type="bibr">27</xref>], and Pathway-Express without cut-offs [<xref rid="pcbi.1008979.ref009" ref-type="bibr">9</xref>] were considered. These methods were chosen as they are not restricted in their input requirements. Over-representation analysis (ORA) type methods were excluded from this analysis as they require a list of differentially expressed genes, assessed using an FDR adjusted two sample t-test with unequal variances, which were almost never detected for low dysregulation values (0.2, 0.3). A similar finding was reported in [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>]. The excluded ORA-type methods were Pathway-Express with cut-offs [<xref rid="pcbi.1008979.ref009" ref-type="bibr">9</xref>], PRS [<xref rid="pcbi.1008979.ref007" ref-type="bibr">7</xref>], SPIA [<xref rid="pcbi.1008979.ref006" ref-type="bibr">6</xref>], and CePA ORA [<xref rid="pcbi.1008979.ref028" ref-type="bibr">28</xref>]. Three other methods, topologyGSA [<xref rid="pcbi.1008979.ref008" ref-type="bibr">8</xref>], PathNet [<xref rid="pcbi.1008979.ref029" ref-type="bibr">29</xref>], and CePa with gene set analysis [<xref rid="pcbi.1008979.ref028" ref-type="bibr">28</xref>] were excluded for other reasons: topologyGSA requires the pathway topology to be a directed acyclic graph (DAG); PathNet has been shown to have uncontrolled type I error [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>]; and CePa with gene set analysis had very low statistical power (near 0) for all dysregulation groups which is likely due to the low levels of mean dysregulation used in our simulations. Due to time considerations, the selected methods were only compared using the breast cancer dataset outlined above. Similar to [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>], all methods control the type I error. DEGraph performs well for pathways with fewer dysregulated genes, but relatively worse for pathways with more dysregulated genes. Conversely, CAMERA and PE.noCut perform relatively better for pathways with higher numbers of dysregulated genes, but relatively worse for pathways with fewer dysregulated genes. The new <monospace>netgsa</monospace> software, NetGSA.REHE.Cl, performs favorably in terms of power and is competitive with the top method across all dysregulated gene groups.</p>
    <sec id="sec008">
      <title>Computational time</title>
      <p>The power analyses performed in the previous section were run in parallel on a cluster with 4 nodes each with two 10-core CPUs and 128GB of memory. For the <monospace>netgsa</monospace> comparison, <monospace>netgsa</monospace> was also timed using REML on the entire network to estimate the variance components (NetGSA.REML.All). This is different than the power results presented in <xref rid="pcbi.1008979.g005" ref-type="fig">Fig 5</xref> which were estimated using REML for each pathway (NetGSA.REML). This difference is because calculating power for REML on the entire network was too computationally expensive, so only 10 iterations for each dataset were timed. The mean and standard deviation of the combined run time for network estimation (<monospace>prepareAdjMat()</monospace>) and pathway enrichment (<monospace>NetGSA()</monospace>) are shown in <xref rid="pcbi.1008979.t001" ref-type="table">Table 1</xref> for the breast cancer and prostate cancer datasets from [<xref rid="pcbi.1008979.ref005" ref-type="bibr">5</xref>]. Estimation with REHE is several times faster than REML and clustering provides an additional large improvement. Separate timing results for network estimation and pathway enrichment are given in <xref rid="pcbi.1008979.s001" ref-type="supplementary-material">S1 Appendix</xref>.</p>
      <table-wrap position="float" id="pcbi.1008979.t001">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1008979.t001</object-id>
        <label>Table 1</label>
        <caption>
          <title>Timing results (in minutes) for NetGSA with REML and REHE with and without network clustering for both the prostate and breast cancer datasets.</title>
        </caption>
        <alternatives>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.1008979.t001" id="pcbi.1008979.t001g" position="float"/>
          <table frame="box" rules="all" border="0">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Method</th>
                <th align="center" rowspan="1" colspan="1">Mean</th>
                <th align="center" rowspan="1" colspan="1">SD</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">NetGSA.REML.All</td>
                <td align="char" char="." rowspan="1" colspan="1">167.83</td>
                <td align="char" char="." rowspan="1" colspan="1">30.69</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">NetGSA.REHE.nCl</td>
                <td align="char" char="." rowspan="1" colspan="1">33.35</td>
                <td align="char" char="." rowspan="1" colspan="1">14.12</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">NetGSA.REHE.Cl</td>
                <td align="char" char="." rowspan="1" colspan="1">4.60</td>
                <td align="char" char="." rowspan="1" colspan="1">1.18</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <p>The computational timing of <monospace>netgsa</monospace> is compared with other existing methods in <xref rid="pcbi.1008979.t002" ref-type="table">Table 2</xref>. While faster than the old <monospace>netgsa</monospace>, the new software is not as fast as the other methods tested, reflecting a potential area for future improvement. It is worth noting that even though <monospace>netgsa</monospace> is still relatively slow, it is now much closer in absolute time to the other methods tested. A chief portion of <monospace>netgsa</monospace>’s computational time is driven by the estimation of the weighted adjacency matrix. While inherently time consuming, this step offers robustness to noise or incompleteness of externally-obtained network information. It also allows <monospace>netgsa</monospace> to assess changes in both mean expression levels as well as network connectivities [<xref rid="pcbi.1008979.ref003" ref-type="bibr">3</xref>, <xref rid="pcbi.1008979.ref013" ref-type="bibr">13</xref>]. Thus, the additional computational time offers appealing features not provided by other existing approaches. Furthermore, <monospace>netgsa</monospace> now comes with additional features from visualization to user interface improvements. Finally, <monospace>netgsa</monospace> offers additional flexibility for multi-condition studies (e.g., more than 2 conditions), and can directly incorporate additional covariates.</p>
      <table-wrap position="float" id="pcbi.1008979.t002">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1008979.t002</object-id>
        <label>Table 2</label>
        <caption>
          <title>Timing results (in minutes) comparing NetGSA with REML and REHE to select methods for breast cancer data.</title>
        </caption>
        <alternatives>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.1008979.t002" id="pcbi.1008979.t002g" position="float"/>
          <table frame="box" rules="all" border="0">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Method</th>
                <th align="center" rowspan="1" colspan="1">Mean</th>
                <th align="center" rowspan="1" colspan="1">SD</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">CAMERA</td>
                <td align="char" char="." rowspan="1" colspan="1">0.0018</td>
                <td align="char" char="." rowspan="1" colspan="1">0.0002</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">DEGraph</td>
                <td align="char" char="." rowspan="1" colspan="1">0.0235</td>
                <td align="char" char="." rowspan="1" colspan="1">0.0007</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PE.noCut</td>
                <td align="char" char="." rowspan="1" colspan="1">0.5162</td>
                <td align="char" char="." rowspan="1" colspan="1">0.0237</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">NetGSA.REHE.Cl</td>
                <td align="char" char="." rowspan="1" colspan="1">4.9464</td>
                <td align="char" char="." rowspan="1" colspan="1">1.1530</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
  </sec>
  <sec id="sec009">
    <title>Availability and future directions</title>
    <p>The updated <monospace>netgsa</monospace> package offers important computational and user interface improvements. It obtains external pathway information from a variety of databases automatically, solving the problem common to many pathway topology-based methods; it also offers intuitive visualizations using the capabilities of Cytoscape. Furthermore, by using network clustering and REHE for estimating the variance components, <monospace>netgsa</monospace> is no longer prohibitively slow. Pathway enrichment analysis with ∼ 2, 500 genes can be performed in minutes on a personal laptop with no loss in statistical power or control of type-I error. With these improvements, we believe <monospace>netgsa</monospace> can now be a useful tool for practitioners, especially when available network information may be noisy or incomplete, or when performing more complex, multi-condition pathway enrichment analysis. The updated NetGSA is available on CRAN at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://cran.r-project.org/web/packages/netgsa/index.html" ext-link-type="uri">https://cran.r-project.org/web/packages/netgsa/index.html</ext-link> and the development version is available on GitHub at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/mikehellstern/netgsa" ext-link-type="uri">https://github.com/mikehellstern/netgsa</ext-link>.</p>
  </sec>
  <sec id="sec010" sec-type="supplementary-material">
    <title>Supporting information</title>
    <supplementary-material id="pcbi.1008979.s001" position="float" content-type="local-data">
      <label>S1 Appendix</label>
      <caption>
        <title>Supporting tables and discussion.</title>
        <p>(PDF)</p>
      </caption>
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pcbi.1008979.s001.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <p>The authors would like to thank the two referees for their insightful comments and suggestions.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="pcbi.1008979.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Khatri</surname><given-names>P</given-names></name>, <name><surname>Sirota</surname><given-names>M</given-names></name>, <name><surname>Butte</surname><given-names>AJ</given-names></name>. <article-title>Ten years of pathway analysis: current approaches and outstanding challenges</article-title>. <source>PLoS computational biology</source>. <year>2012</year>;<volume>8</volume>(<issue>2</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002375</pub-id><?supplied-pmid 22383865?><pub-id pub-id-type="pmid">22383865</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>L</given-names></name>, <name><surname>Zuo</surname><given-names>XY</given-names></name>, <name><surname>Su</surname><given-names>WY</given-names></name>, <name><surname>Zhao</surname><given-names>XL</given-names></name>, <name><surname>Yuan</surname><given-names>MQ</given-names></name>, <name><surname>Han</surname><given-names>LZ</given-names></name>, <etal>et al</etal>. <article-title>Pathway-based analysis tools for complex diseases: a review</article-title>. <source>Genomics, proteomics &amp; bioinformatics</source>. <year>2014</year>;<volume>12</volume>(<issue>5</issue>):<fpage>210</fpage>–<lpage>220</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.gpb.2014.10.002</pub-id><?supplied-pmid 25462153?><pub-id pub-id-type="pmid">25462153</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>J</given-names></name>, <name><surname>Shojaie</surname><given-names>A</given-names></name>, <name><surname>Michailidis</surname><given-names>G</given-names></name>. <article-title>Network-based pathway enrichment analysis with incomplete network information</article-title>. <source>Bioinformatics</source>. <year>2016</year>;<volume>32</volume>(<issue>20</issue>):<fpage>3165</fpage>–<lpage>3174</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btw410</pub-id><?supplied-pmid 27357170?><pub-id pub-id-type="pmid">27357170</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Shojaie</surname><given-names>A</given-names></name>, <name><surname>Michailidis</surname><given-names>G</given-names></name>. <article-title>Analysis of gene sets based on the underlying regulatory network</article-title>. <source>Journal of Computational Biology</source>. <year>2009</year>;<volume>16</volume>(<issue>3</issue>):<fpage>407</fpage>–<lpage>426</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1089/cmb.2008.0081</pub-id><?supplied-pmid 19254181?><pub-id pub-id-type="pmid">19254181</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>J</given-names></name>, <name><surname>Shojaie</surname><given-names>A</given-names></name>, <name><surname>Michailidis</surname><given-names>G</given-names></name>. <article-title>A comparative study of topology-based pathway enrichment analysis methods</article-title>. <source>BMC bioinformatics</source>. <year>2019</year>;<volume>20</volume>(<issue>1</issue>):<fpage>546</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12859-019-3146-1</pub-id><?supplied-pmid 31684881?><pub-id pub-id-type="pmid">31684881</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Tarca</surname><given-names>AL</given-names></name>, <name><surname>Draghici</surname><given-names>S</given-names></name>, <name><surname>Khatri</surname><given-names>P</given-names></name>, <name><surname>Hassan</surname><given-names>SS</given-names></name>, <name><surname>Mittal</surname><given-names>P</given-names></name>, Kim Js, <etal>et al</etal>. <article-title>A novel signaling pathway impact analysis</article-title>. <source>Bioinformatics</source>. <year>2009</year>;<volume>25</volume>(<issue>1</issue>):<fpage>75</fpage>–<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btn577</pub-id><?supplied-pmid 18990722?><pub-id pub-id-type="pmid">18990722</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>Ibrahim</surname><given-names>MAH</given-names></name>, <name><surname>Jassim</surname><given-names>S</given-names></name>, <name><surname>Cawthorne</surname><given-names>MA</given-names></name>, <name><surname>Langlands</surname><given-names>K</given-names></name>. <article-title>A topology-based score for pathway enrichment</article-title>. <source>Journal of Computational Biology</source>. <year>2012</year>;<volume>19</volume>(<issue>5</issue>):<fpage>563</fpage>–<lpage>573</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1089/cmb.2011.0182</pub-id><?supplied-pmid 22468678?><pub-id pub-id-type="pmid">22468678</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><name><surname>Massa</surname><given-names>MS</given-names></name>, <name><surname>Chiogna</surname><given-names>M</given-names></name>, <name><surname>Romualdi</surname><given-names>C</given-names></name>. <article-title>Gene set analysis exploiting the topology of a pathway</article-title>. <source>BMC systems biology</source>. <year>2010</year>;<volume>4</volume>(<issue>1</issue>):<fpage>121</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1752-0509-4-121</pub-id><?supplied-pmid 20809931?><pub-id pub-id-type="pmid">20809931</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Draghici</surname><given-names>S</given-names></name>, <name><surname>Khatri</surname><given-names>P</given-names></name>, <name><surname>Tarca</surname><given-names>AL</given-names></name>, <name><surname>Amin</surname><given-names>K</given-names></name>, <name><surname>Done</surname><given-names>A</given-names></name>, <name><surname>Voichita</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>A systems biology approach for pathway level analysis</article-title>. <source>Genome research</source>. <year>2007</year>;<volume>17</volume>(<issue>10</issue>):<fpage>1537</fpage>–<lpage>1545</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/gr.6202607</pub-id><?supplied-pmid 17785539?><pub-id pub-id-type="pmid">17785539</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Kanehisa</surname><given-names>M</given-names></name>, <name><surname>Goto</surname><given-names>S</given-names></name>. <article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title>. <source>Nucleic acids research</source>. <year>2000</year>;<volume>28</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id><?supplied-pmid 10592173?><pub-id pub-id-type="pmid">10592173</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Fabregat</surname><given-names>A</given-names></name>, <name><surname>Jupe</surname><given-names>S</given-names></name>, <name><surname>Matthews</surname><given-names>L</given-names></name>, <name><surname>Sidiropoulos</surname><given-names>K</given-names></name>, <name><surname>Gillespie</surname><given-names>M</given-names></name>, <name><surname>Garapati</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>The reactome pathway knowledgebase</article-title>. <source>Nucleic acids research</source>. <year>2018</year>;<volume>46</volume>(<issue>D1</issue>):<fpage>D649</fpage>–<lpage>D655</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkx1132</pub-id><?supplied-pmid 29145629?><pub-id pub-id-type="pmid">29145629</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>PD</given-names></name>, <name><surname>Campbell</surname><given-names>MJ</given-names></name>, <name><surname>Kejariwal</surname><given-names>A</given-names></name>, <name><surname>Mi</surname><given-names>H</given-names></name>, <name><surname>Karlak</surname><given-names>B</given-names></name>, <name><surname>Daverman</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>PANTHER: a library of protein families and subfamilies indexed by function</article-title>. <source>Genome research</source>. <year>2003</year>;<volume>13</volume>(<issue>9</issue>):<fpage>2129</fpage>–<lpage>2141</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/gr.772403</pub-id><?supplied-pmid 12952881?><pub-id pub-id-type="pmid">12952881</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Shojaie</surname><given-names>A</given-names></name>, <name><surname>Michailidis</surname><given-names>G</given-names></name>. <article-title>Network enrichment analysis in complex experiments</article-title>. <source>Statistical applications in genetics and molecular biology</source>. <year>2010</year>;<volume>9</volume>(<issue>1</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.2202/1544-6115.1483</pub-id><?supplied-pmid 20597848?><pub-id pub-id-type="pmid">20597848</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Sales</surname><given-names>G</given-names></name>, <name><surname>Calura</surname><given-names>E</given-names></name>, <name><surname>Cavalieri</surname><given-names>D</given-names></name>, <name><surname>Romualdi</surname><given-names>C</given-names></name>. <article-title>graphite-a Bioconductor package to convert pathway topology to gene network</article-title>. <source>BMC bioinformatics</source>. <year>2012</year>;<volume>13</volume>(<issue>1</issue>):<fpage>20</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2105-13-20</pub-id><?supplied-pmid 22292714?><pub-id pub-id-type="pmid">22292714</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>Pratt</surname><given-names>D</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Welker</surname><given-names>D</given-names></name>, <name><surname>Rivas</surname><given-names>R</given-names></name>, <name><surname>Pillich</surname><given-names>R</given-names></name>, <name><surname>Rynkov</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>NDEx, the network data exchange</article-title>. <source>Cell systems</source>. <year>2015</year>;<volume>1</volume>(<issue>4</issue>):<fpage>302</fpage>–<lpage>305</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cels.2015.10.001</pub-id><?supplied-pmid 26594663?><pub-id pub-id-type="pmid">26594663</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Nishimura</surname><given-names>D</given-names></name>. <article-title>BioCarta</article-title>. <source>Biotech Software &amp; Internet Report</source>. <year>2001</year>;<volume>2</volume>(<issue>3</issue>):<fpage>117</fpage>–<lpage>120</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1089/152791601750294344</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Schaefer</surname><given-names>CF</given-names></name>, <name><surname>Anthony</surname><given-names>K</given-names></name>, <name><surname>Krupa</surname><given-names>S</given-names></name>, <name><surname>Buchoff</surname><given-names>J</given-names></name>, <name><surname>Day</surname><given-names>M</given-names></name>, <name><surname>Hannay</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>PID: the pathway interaction database</article-title>. <source>Nucleic acids research</source>. <year>2009</year>;<volume>37</volume>(<issue>suppl_1</issue>):<fpage>D674</fpage>–<lpage>D679</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkn653</pub-id><?supplied-pmid 18832364?><pub-id pub-id-type="pmid">18832364</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Wishart</surname><given-names>DS</given-names></name>, <name><surname>Li</surname><given-names>C</given-names></name>, <name><surname>Marcu</surname><given-names>A</given-names></name>, <name><surname>Badran</surname><given-names>H</given-names></name>, <name><surname>Pon</surname><given-names>A</given-names></name>, <name><surname>Budinski</surname><given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>PathBank: a comprehensive pathway database for model organisms</article-title>. <source>Nucleic acids research</source>. <year>2020</year>;<volume>48</volume>(<issue>D1</issue>):<fpage>D470</fpage>–<lpage>D478</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkz861</pub-id><?supplied-pmid 31602464?><pub-id pub-id-type="pmid">31602464</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Jewison</surname><given-names>T</given-names></name>, <name><surname>Su</surname><given-names>Y</given-names></name>, <name><surname>Disfany</surname><given-names>FM</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name>, <name><surname>Knox</surname><given-names>C</given-names></name>, <name><surname>Maciejewski</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>SMPDB 2.0: big improvements to the Small Molecule Pathway Database</article-title>. <source>Nucleic acids research</source>. <year>2014</year>;<volume>42</volume>(<issue>D1</issue>):<fpage>D478</fpage>–<lpage>D484</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkt1067</pub-id><?supplied-pmid 24203708?><pub-id pub-id-type="pmid">24203708</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>Whirl-Carrillo</surname><given-names>M</given-names></name>, <name><surname>McDonagh</surname><given-names>EM</given-names></name>, <name><surname>Hebert</surname><given-names>J</given-names></name>, <name><surname>Gong</surname><given-names>L</given-names></name>, <name><surname>Sangkuhl</surname><given-names>K</given-names></name>, <name><surname>Thorn</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Pharmacogenomics knowledge for personalized medicine</article-title>. <source>Clinical Pharmacology &amp; Therapeutics</source>. <year>2012</year>;<volume>92</volume>(<issue>4</issue>):<fpage>414</fpage>–<lpage>417</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/clpt.2012.96</pub-id><?supplied-pmid 22992668?><pub-id pub-id-type="pmid">22992668</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Shannon</surname><given-names>P</given-names></name>, <name><surname>Markiel</surname><given-names>A</given-names></name>, <name><surname>Ozier</surname><given-names>O</given-names></name>, <name><surname>Baliga</surname><given-names>NS</given-names></name>, <name><surname>Wang</surname><given-names>JT</given-names></name>, <name><surname>Ramage</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome research</source>. <year>2003</year>;<volume>13</volume>(<issue>11</issue>):<fpage>2498</fpage>–<lpage>2504</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><?supplied-pmid 14597658?><pub-id pub-id-type="pmid">14597658</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>Koboldt</surname><given-names>DC</given-names></name>, <name><surname>Fulton</surname><given-names>RS</given-names></name>, <name><surname>McLellan</surname><given-names>MD</given-names></name>, <name><surname>Schmidt</surname><given-names>H</given-names></name>, <name><surname>Kalicki-Veizer</surname><given-names>J</given-names></name>, <name><surname>McMichael</surname><given-names>JF</given-names></name>, <etal>et al</etal>. <article-title>Comprehensive molecular portraits of human breast tumours</article-title>. <source>Nature</source>. <year>2012</year>;<volume>490</volume>(<issue>7418</issue>):<fpage>61</fpage>–<lpage>70</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature11412</pub-id><pub-id pub-id-type="pmid">23000897</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Yue</surname><given-names>K</given-names></name>, <name><surname>Ma</surname><given-names>J</given-names></name>, <name><surname>Thornton</surname><given-names>T</given-names></name>, <name><surname>Shojaie</surname><given-names>A</given-names></name>. <article-title>REHE: Fast Variance Components Estimation for Linear Mixed Models</article-title>. <source>bioRxiv</source>. <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/2021.02.03.429643</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Abeshouse</surname><given-names>A</given-names></name>, <name><surname>Ahn</surname><given-names>J</given-names></name>, <name><surname>Akbani</surname><given-names>R</given-names></name>, <name><surname>Ally</surname><given-names>A</given-names></name>, <name><surname>Amin</surname><given-names>S</given-names></name>, <name><surname>Andry</surname><given-names>CD</given-names></name>, <etal>et al</etal>. <article-title>The molecular taxonomy of primary prostate cancer</article-title>. <source>Cell</source>. <year>2015</year>;<volume>163</volume>(<issue>4</issue>):<fpage>1011</fpage>–<lpage>1025</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2015.10.025</pub-id><pub-id pub-id-type="pmid">26544944</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>Fahrmann</surname><given-names>J</given-names></name>, <name><surname>Grapov</surname><given-names>D</given-names></name>, <name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Hammock</surname><given-names>B</given-names></name>, <name><surname>Fiehn</surname><given-names>O</given-names></name>, <name><surname>Bell</surname><given-names>GI</given-names></name>, <etal>et al</etal>. <article-title>Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia</article-title>. <source>American Journal of Physiology-Endocrinology and Metabolism</source>. <year>2015</year>;<volume>308</volume>(<issue>11</issue>):<fpage>E978</fpage>–<lpage>E989</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/ajpendo.00019.2015</pub-id><?supplied-pmid 25852003?><pub-id pub-id-type="pmid">25852003</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Jacob</surname><given-names>L</given-names></name>, <name><surname>Neuvial</surname><given-names>P</given-names></name>, <name><surname>Dudoit</surname><given-names>S</given-names></name>. <article-title>More power via graph-structured tests for differential expression of gene networks</article-title>. <source>The Annals of Applied Statistics</source>. <year>2012</year>; p. <fpage>561</fpage>–<lpage>600</lpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref027">
      <label>27</label>
      <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>D</given-names></name>, <name><surname>Smyth</surname><given-names>GK</given-names></name>. <article-title>Camera: a competitive gene set test accounting for inter-gene correlation</article-title>. <source>Nucleic acids research</source>. <year>2012</year>;<volume>40</volume>(<issue>17</issue>):<fpage>e133</fpage>–<lpage>e133</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gks461</pub-id><?supplied-pmid 22638577?><pub-id pub-id-type="pmid">22638577</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref028">
      <label>28</label>
      <mixed-citation publication-type="journal"><name><surname>Gu</surname><given-names>Z</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Cao</surname><given-names>K</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>. <article-title>Centrality-based pathway enrichment: a systematic approach for finding significant pathways dominated by key genes</article-title>. <source>BMC systems biology</source>. <year>2012</year>;<volume>6</volume>(<issue>1</issue>):<fpage>56</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1752-0509-6-56</pub-id><?supplied-pmid 22672776?><pub-id pub-id-type="pmid">22672776</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008979.ref029">
      <label>29</label>
      <mixed-citation publication-type="journal"><name><surname>Dutta</surname><given-names>B</given-names></name>, <name><surname>Wallqvist</surname><given-names>A</given-names></name>, <name><surname>Reifman</surname><given-names>J</given-names></name>. <article-title>PathNet: a tool for pathway analysis using topological information</article-title>. <source>Source code for biology and medicine</source>. <year>2012</year>;<volume>7</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1751-0473-7-10</pub-id><?supplied-pmid 23006764?><pub-id pub-id-type="pmid">22333270</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
